<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAE7F8F7-1B15-47CA-844D-044010E02914"><gtr:id>DAE7F8F7-1B15-47CA-844D-044010E02914</gtr:id><gtr:name>University of Hasselt</gtr:name><gtr:address><gtr:line1>Campus Diepenbeek</gtr:line1><gtr:line2>Agoralaan Gebouw D</gtr:line2><gtr:line3>BE 3590</gtr:line3><gtr:line4>Diepenbeek</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A88086FE-C28F-4863-8B2B-1A97734A6C79"><gtr:id>A88086FE-C28F-4863-8B2B-1A97734A6C79</gtr:id><gtr:name>University of Strasbourg</gtr:name><gtr:address><gtr:line1>Universite Louis Pasteur</gtr:line1><gtr:line2>4 rue Blaise Pascal</gtr:line2><gtr:line4>Strasbourg</gtr:line4><gtr:line5>Cedex</gtr:line5><gtr:postCode>67070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/FAD72F10-05DD-4B4D-89F4-0475C2A79E10"><gtr:id>FAD72F10-05DD-4B4D-89F4-0475C2A79E10</gtr:id><gtr:name>School of Pharmacy</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>29-39 Brunswick Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 1AX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FAD72F10-05DD-4B4D-89F4-0475C2A79E10"><gtr:id>FAD72F10-05DD-4B4D-89F4-0475C2A79E10</gtr:id><gtr:name>School of Pharmacy</gtr:name><gtr:address><gtr:line1>29-39 Brunswick Square</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 1AX</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAE7F8F7-1B15-47CA-844D-044010E02914"><gtr:id>DAE7F8F7-1B15-47CA-844D-044010E02914</gtr:id><gtr:name>University of Hasselt</gtr:name><gtr:address><gtr:line1>Campus Diepenbeek</gtr:line1><gtr:line2>Agoralaan Gebouw D</gtr:line2><gtr:line3>BE 3590</gtr:line3><gtr:line4>Diepenbeek</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A88086FE-C28F-4863-8B2B-1A97734A6C79"><gtr:id>A88086FE-C28F-4863-8B2B-1A97734A6C79</gtr:id><gtr:name>University of Strasbourg</gtr:name><gtr:address><gtr:line1>Universite Louis Pasteur</gtr:line1><gtr:line2>4 rue Blaise Pascal</gtr:line2><gtr:line4>Strasbourg</gtr:line4><gtr:line5>Cedex</gtr:line5><gtr:postCode>67070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7479EFF8-8EF7-479B-BB26-3D844EB92D8E"><gtr:id>7479EFF8-8EF7-479B-BB26-3D844EB92D8E</gtr:id><gtr:name>University of Goettingen</gtr:name><gtr:address><gtr:line1>Windausweg 2</gtr:line1><gtr:postCode>D-37073</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6C3234E-5048-4AA0-A116-0CAC51569B2D"><gtr:id>D6C3234E-5048-4AA0-A116-0CAC51569B2D</gtr:id><gtr:name>University of Queensland</gtr:name><gtr:address><gtr:line1>University of Queensland</gtr:line1><gtr:line4>Brisbane</gtr:line4><gtr:line5>Queensland 4972</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B3503266-26C5-4388-B835-3B426FDEADB5"><gtr:id>B3503266-26C5-4388-B835-3B426FDEADB5</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Justin</gtr:otherNames><gtr:surname>Harvey</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/78132E4B-F641-45DF-A5A9-D1CF2558D7C4"><gtr:id>78132E4B-F641-45DF-A5A9-D1CF2558D7C4</gtr:id><gtr:firstName>Trevor Graeme</gtr:firstName><gtr:surname>Smart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9408C098-D406-49FD-AB23-F608AF7EC776"><gtr:id>9408C098-D406-49FD-AB23-F608AF7EC776</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>Henry</gtr:otherNames><gtr:surname>Dickenson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23265357-ADC7-41A0-BCC1-77B9BFCFBF30"><gtr:id>23265357-ADC7-41A0-BCC1-77B9BFCFBF30</gtr:id><gtr:firstName>Terence</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Dear</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500833"><gtr:id>DE0E6412-1B03-4E09-A819-169E5F0B2E3F</gtr:id><gtr:title>Biological and therapeutic roles of glycine receptors containing the alpha2 or alpha3 subunits</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500833</gtr:grantReference><gtr:abstractText>The central nervous system (CNS) is a complex, intricate network of nerve cells (neurones) whose primary function is to transmit and receive messages. This communication occurs at specialised sites of contact known as synapses. At these sites, an arriving nerve impulse causes the release of a chemical (neurotransmitter) which then interacts with receptor molecules embedded in the cell membrane of a neighbouring neurone. Some types of these receptors (e.g. glycine receptors) possess specific ion-permeable channels. The opening of these channels in response to neurotransmitter alters the electrical state of the cell either transmitting or subtly altering the incoming nerve impulse. The molecular mechanisms that regulate synaptic transmission and nerve impulse activity are important in understanding normal and diseased states of the brain. Indeed, many major drugs act primarily via receptor/ion channels. The therapeutic nature of these agents provides a compelling reason for further understanding the molecular details of the structure and function of this receptor class. 

This proposal will benefit research in this area by enhancing our knowledge concerning glycine receptors, inhibitory ion channels found mainly in the spinal cord and brainstem. Animal models and human studies of glycine receptors have shown that one receptor subtype (called alpha1) is involved in a rare neurological disorder (startle disease). By creating a knockout mouse where the gene for another subtype (alpha3) was disrupted, we found that this was important in inflammatory pain. New therapeutic targets for inflammatory and chronic pain are a current clinical need given that the long-term use of classical analgesics is hampered by severe side effects such as gastric ulcerations leading to significant mortality in the elderly or, for the COX2 inhibitors, a predisposition to heart attacks and stroke. Our major aims are: i) to characterise molecular variants and locations of the alpha2 and alpha3 GlyRs in the CNS; ii) to assess the contribution of the glycine receptor alpha3 subunit to inflammatory and chronic pain; iii) to discover drugs might positively modulate glycine receptors containing the alpha1 versus alpha3 subunits, the first step in developing new treatments for pain; iv) to discover the role of the alpha2 subtype by creating a knockout mouse which will lack these receptors. Taken together, our studies will inform the development of new therapeutic treatments for inflammatory and/or chronic pain and may uncover human disorders involving defects in the alpha2 subunit gene.</gtr:abstractText><gtr:technicalSummary>We have recently revealed a new important role for inhibitory glycine receptors (GlyRs) containing the alpha3 subunit in prostaglandin-mediated inflammatory pain sensitisation (see Harvey et al., 2004, Science 304:884-887). This programme aims to: i) assess RNA editing and sites of expression of alpha2 and alpha3 subunit GlyRs; ii) examine the role of GlyR alpha3 in models of neuropathic pain; iii) study allosteric modulation of GlyRs by existing and novel compounds with potential therapeutic implications; and iv) generate a knockout model for the alpha2 GlyR subtype, which has been implicated in the formation of glycinergic synapses, cortical differentiation and rod photoreceptor development. This study will bring together molecular, behavioural, electrophysiological and gene knockout expertise to define the emerging biological and potential therapeutic roles of glycine receptors.</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>517921</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute for Brain Research</gtr:department><gtr:description>Mapping of glycine receptor expression patterns in retina</gtr:description><gtr:id>FE29F2E4-3747-4907-B45D-3F0A0CA71337</gtr:id><gtr:impact>These studies have revealed that the GlyR alpha4 subunit potentially forms a heteromeric receptor with GlyR alpha2. This co-distribution has since been confirmed in other tissues and has implications for our Glra2 knockout study, since GlyR alpha4 may compensate for loss of GlyR alpha2. PubMed IDs: 17154252, 19924257.</gtr:impact><gtr:outcomeId>A9AD7CA7271-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators mapped the expression patterns of GlyR alpha2, alpha3 and alpha4 subunits in retina</gtr:partnerContribution><gtr:piContribution>Our research team developed subunit-specific antibodies for the GlyR alpha2, alpha3 and alpha4 subunits, which were provided to Professor Waessle for this collaborative project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Louis Pasteur University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Presynaptic compensation in Glra3 knockout mice</gtr:description><gtr:id>8915E7E8-8EC1-4ECE-8527-A068AADE0156</gtr:id><gtr:impact>This study explains why GlyR alpha3 knockout mouse display an inflammatory pain phenotype: presynaptic compensation maintains glycinergic transmission via GlyR alpha1beta receptors in the GlyR alpha3 knockout, but alpha1 does not contain the PKA phosphorylation site modified by activation of the EP2 receptor. PubMed ID: 20092571. This collaboration was multidisciplinary, involving molecular biology, genetics and electrophysiology.</gtr:impact><gtr:outcomeId>EE25ECA50E5-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators determined that glycinergic synapses in lamina II of the dorsal horn show presynaptic compensation for the loss of GlyR alpha3.</gtr:partnerContribution><gtr:piContribution>Our research team used quantitative RT-PCR to determine that in GlyR alpha3 knockout mice, deleting Glra3 exon 7 decreases levels of GlyR alpha3 transcripts, but surprisingly no compensatory increase in GlyR alpha1, alpha2 or alpha4 subunit gene expression was observed. This observation lead us study presynaptic compensation using electrophysiological methods.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Hasselt</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>BIOMED Research Institute</gtr:department><gtr:description>Phenotyping Glra2 knockout mice</gtr:description><gtr:id>3DB6223C-5E9F-435F-A140-2A90E4B0A1B2</gtr:id><gtr:impact>The collaboration with the University of Hasselt was pivotal in understanding the biological role of GlyRs containing the a2 subunit. We discovered that extrasynaptic activation of a2 subunit GlyRs in cortical interneurons by endogenous glycine activates voltage-gated calcium channels and promotes calcium influx. This signalling pathway modulates actomyosin contractility to fine-tune nuclear translocation during migration. The studies also suggest that defects in the human GlyR alpha2 subunit gene may lead to microcephaly in humans. PubMed IDs: 23954789; 24926615, 26891984. Collaboration with INSERM U1130 partners revealed a link between GlyRs a2 mutations and autism spectrum disorder. PubMed ID:
26370147. These collaborations collaboration are multidisciplinary, involving mouse genetics and behaviour, and neuronal migration analysis via imaging and electrophysiology.</gtr:impact><gtr:outcomeId>eq2UCjYNJyL-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators at the University of Hasselt found that GlyRs are expressed by embryonic cortical interneurons in vivo, and that genetic disruption of Glra2 leads to interneuron migration defects. In a follow-up study, we found that ablation of Glra2 disrupts dorsal cortical progenitor homeostasis, resulting in an overall reduction of projection neurons that settle in upper or deep layers of the cerebral cortex. This depletion of cortical neurons leads to moderate microcephaly in newborn Glra2 knockout mice. Collaborators at INSERM U1130 found that Glra2 knockout mice exhibited deficits in object recognition memory and impaired long-term potentiation in the prefrontal cortex.</gtr:partnerContribution><gtr:piContribution>Our team generated Glra2 knockout mice, where exon 7 had been removed by homologous recombination and devised this collaboration, to examine the role of GlyR alpha2 in cortical migration during synaptogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Inserm U1130 Neuroscience Department Paris Seine</gtr:department><gtr:description>Phenotyping Glra2 knockout mice</gtr:description><gtr:id>87E27769-6844-4079-9A9E-7F779750D2EB</gtr:id><gtr:impact>The collaboration with the University of Hasselt was pivotal in understanding the biological role of GlyRs containing the a2 subunit. We discovered that extrasynaptic activation of a2 subunit GlyRs in cortical interneurons by endogenous glycine activates voltage-gated calcium channels and promotes calcium influx. This signalling pathway modulates actomyosin contractility to fine-tune nuclear translocation during migration. The studies also suggest that defects in the human GlyR alpha2 subunit gene may lead to microcephaly in humans. PubMed IDs: 23954789; 24926615, 26891984. Collaboration with INSERM U1130 partners revealed a link between GlyRs a2 mutations and autism spectrum disorder. PubMed ID:
26370147. These collaborations collaboration are multidisciplinary, involving mouse genetics and behaviour, and neuronal migration analysis via imaging and electrophysiology.</gtr:impact><gtr:outcomeId>eq2UCjYNJyL-2</gtr:outcomeId><gtr:partnerContribution>Our collaborators at the University of Hasselt found that GlyRs are expressed by embryonic cortical interneurons in vivo, and that genetic disruption of Glra2 leads to interneuron migration defects. In a follow-up study, we found that ablation of Glra2 disrupts dorsal cortical progenitor homeostasis, resulting in an overall reduction of projection neurons that settle in upper or deep layers of the cerebral cortex. This depletion of cortical neurons leads to moderate microcephaly in newborn Glra2 knockout mice. Collaborators at INSERM U1130 found that Glra2 knockout mice exhibited deficits in object recognition memory and impaired long-term potentiation in the prefrontal cortex.</gtr:partnerContribution><gtr:piContribution>Our team generated Glra2 knockout mice, where exon 7 had been removed by homologous recombination and devised this collaboration, to examine the role of GlyR alpha2 in cortical migration during synaptogenesis.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of G?ttingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Phenotyping Glra3 knockout mice</gtr:description><gtr:id>9F6C3258-4351-41F0-BE29-9C6061100433</gtr:id><gtr:impact>GlyRs containing alpha3 modulate the activity of the respiratory network due to modulation by 5HT1A receptor stimulation of protein kinase A. This new signaling pathway is of therapeutic significance, since serotonin receptor 1A-directed pharmacotherapy was able to reverse opioid-induced apnea in wild-type but not Glra3 knockout mice. PubMed ID: 20978350. This collaboration was multidisciplinary, involving biochemistry, molecular biology, genetics and electrophysiology.</gtr:impact><gtr:outcomeId>DC915A38D97-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators found that GlyR alpha3 is expressed in identified respiratory neurons in the pre-Boetzinger complex and that GlyR alpha3 knockout mice have defective breathing patterns.</gtr:partnerContribution><gtr:piContribution>Our team developed a provided standard and phospho-specific GlyR alpha3 subunit antibodies for this study, as well as Glra3 knockout mice. We also reconstituted the 5HT1A-GlyR signalling pathway in HEK293 cells, showing that activation of the 5HT1A receptor was capable of enhancing glycine-mediated currents mediated by GlyRs containing alpha3.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Queensland</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Subunit-specific modulators of glycine receptors</gtr:description><gtr:id>98CDE8C6-E77D-4399-BCBC-40D0B9D80609</gtr:id><gtr:impact>Different GlyR subtypes show distinct profiles for potentiation or inhibition by picrotoxin/picrotin, dihydropyridines and cannabinoids. PubMed IDs: 17714449, 18657556, 18755158. This collaboration was multidisciplinary, involving molecular biology and electrophysiology.</gtr:impact><gtr:outcomeId>716F2B7B093-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators examined the pharmacology of possible subtype-specific modulators of GlyRs including picrotoxin/picrotin, dihydropyridines and cannabinoids.</gtr:partnerContribution><gtr:piContribution>Our research team provided expression constructs for rat and human GlyR subunits and advised on possible subtype-selective modulators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Rhine/Mainz/Max Planck plenary: Plasticity of synaptic and extrasynaptic inhibitory transmission</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3B1CC1E9-10A5-4F0A-ADA4-E3024BF7F46E</gtr:id><gtr:impact>This plenary lecture was delivered at the first major symposium between these German Universities and Max Planck. The PI talked to postgraduates about research following the plenary lecture.

Postgraduates visited the PIs laboratory.</gtr:impact><gtr:outcomeId>esQTG2dsT7U</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Caf? Scientifique Event, UCL</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>47170B72-844E-45DE-8693-EB5F0D8C7007</gtr:id><gtr:impact>Talk on genetics and wellbeing at a Caf&amp;eacute; Scientifique Event, Roberts Building, UCL (19th April 2013) organised through the UCL Public Engagement Unit. The audience consisted of 30 members of the University of The Third Age from North London.

Further invitation to talk at the UCL Science Society (http://www.ucl.ac.uk/science-society/), whose members are drawn from all branches of the Sciences</gtr:impact><gtr:outcomeId>nR6NZkFTEAg</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC Health article</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>70365C8E-4DC2-4D20-9C5D-406AB6B1DA18</gtr:id><gtr:impact>Coverage of startle disease research outcomes and new research funding in awareness article on BBC Health website.

Increased awareness of startle disease impacts on affected children and families; Enquiries from scientists, clinicians and members of the public.</gtr:impact><gtr:outcomeId>AbV5qEBuEWG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/news/health-18911272</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Awareness Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2C971661-8137-457D-B87B-A505930BED26</gtr:id><gtr:impact>The School of Pharmacy currently hosts the London Chapter of the Society for Neuroscience (http://www.sfnlondonchapter.org/) which organises activities such as annual meetings, seminars and young scientist workshops during Brain Awareness Week, with the aim of engaging and educating a new generation of neuroscientists and raising public awareness and interest in neuroscience research.

Staff and PhD students becoming members of the London Chapter of the Society for Neuroscience.</gtr:impact><gtr:outcomeId>Cs2rP6TvqZe</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Distinguished Gowdey Prize Lecture in Pharmacology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>A06117F5-F16E-43EF-98DD-65619AE040DE</gtr:id><gtr:impact>Attended postgraduate posters and talked to postgraduates about research following prize lecture.

Research collaborations</gtr:impact><gtr:outcomeId>mVH1syzpa2c</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at the UCL Science Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>29869B95-6B72-4897-9CA8-34CA4D9E780E</gtr:id><gtr:impact>Lecture at the UCL Science Society - Defective inhibitory neurotransmission in startle disease: some surprising findings (27th Feb 2014) audience made up of UCL students, staff, alumni and guests.

After talk members of the UCL Science Society made further requests for information about my work and asked to visit my laboratory.</gtr:impact><gtr:outcomeId>545caa8a418df5.62611882</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/pharmacy/research/disease-models-and-clinical-pharmacology/disease-models-news/ucl-ssl</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to Croydon High School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FEAA1D77-6D55-41F0-9742-E0B8AF5A1D62</gtr:id><gtr:impact>~150 pupils attended an informal talk on neuroscience and pharmacology.

Pupils applied and two came to gain experience in the laboratory.</gtr:impact><gtr:outcomeId>o7oJLxsSzYN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Highlighting MRC-funded research on UCL School of Pharmacy web portal</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A969C7BA-F5A1-47E5-93E2-4A6F5D76729B</gtr:id><gtr:impact>We have publicised new research findings via the UCL School of Pharmacy web portals, see e.g. http://www.ucl.ac.uk/pharmacy/news/startle

Parents of individuals with hyperekplexia or referring clinicians contacting PIs by E-mail or letter regarding genetic screening.</gtr:impact><gtr:outcomeId>YwLKQJqLuBc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School of Pharmacy Annual Review</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A9DD27ED-E90A-41A6-901A-53905EACBB76</gtr:id><gtr:impact>In an article entitled 'Focus on Neuroscience: Genetic research brings new insights into CNS disorders', we reviewed our work on glycine receptors and hyperekplexia in lay language.

Increased awareness of MRC-funded research into glycine receptors and hyperekplexia at the School of Pharmacy and other report recipients.</gtr:impact><gtr:outcomeId>F7D87CFF903</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>Norway, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Joint funded PhD studentship/UCL/Uni Research AS Norway</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Uni Research AS</gtr:fundingOrg><gtr:id>14053425-680C-4332-8983-C892109E8EFF</gtr:id><gtr:outcomeId>MQW2Zu3kfuA0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Joint funded PhD studentship/UCL/VU University Amsterdam</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Free University of Amsterdam</gtr:fundingOrg><gtr:id>220B2A8C-B137-4B9D-8AF7-C69E81DB2450</gtr:id><gtr:outcomeId>MQW2Zu3kfuA1</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC DTG four-year PhD studentship</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800111</gtr:fundingRef><gtr:id>32DD1FCB-7AB3-42EE-8FAD-44C4AF2242E3</gtr:id><gtr:outcomeId>oQMvTVVA24z0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1015020</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800498</gtr:fundingRef><gtr:id>B9CD06FA-946B-474B-A995-AD03C46B28B2</gtr:id><gtr:outcomeId>EC1186AB0E30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>New experimentally-induced mouse models of osteoarthritis and neuropathy were developed in C57Bl/6 mice and characterised at the behavioural and electrophysiological levels.</gtr:description><gtr:id>E1749C29-B20F-463C-AEE1-72A5F143A5C1</gtr:id><gtr:impact>These models enabled us to characterise the role of the glycine receptor alpha3 subunit in mouse models of inflammatory and chronic pain including: i) Neuropathic models - Partial Sciatic Nerve Ligation; ii) Inflammatory models - Persistent inflammatory pain: Freund's complete adjuvant (CFA), Acute inflammatory pain: carrageenan, capsaicin; iii) Arthritis models - rheumatoid arthritis (kaolin/carageenan), osteoarthritis (monosodium iodoacetate) and iv) cancer-induced bone pain. See PubMed IDs 19379487, 19915732.</gtr:impact><gtr:outcomeId>8D82ACD5CBC</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>New mouse models of osteoarthritis and neuropathy</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19379487</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We successfully generated a glycine receptor alpha2 subunit mouse knockout line by homologous recombination in PC3 ES cells, removing Glra2 exon 7 by Cre-mediated recombination. After preliminary phenotyping at the University of Leeds, mice have been provided to the German Mouse Clinic (GMC) for further detailed phenotyping.</gtr:description><gtr:id>2EBE7BE4-4F4A-40B6-BC88-8676FF2584CD</gtr:id><gtr:impact>Phenotype(s) found in Glra2 knockout mice have been characterised in detail by the GMC. We have two ongoing collaborations to examine the biological role of glra2 in more detail: i) with Catalina Betancur at the Universit Pierre et Marie Curie, we are exploring the hypothesis that glra2 defects are a rare cause of autism; ii) with Jean-Michel Rigo at Hasselt University, we are examining the role of glra2 in cortical interneuron tangential migration. The latter has recently given rise to publications showing that GlyR alpha2 subunit activation promotes cortical interneuron migration. PubMed IDs: 23954789; 24926615, 26891984.</gtr:impact><gtr:outcomeId>08CD6770EFA</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Glycine receptor alpha2 subunit knockout mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://www.sciencedirect.com/science/article/pii/S2211124713003781</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D45A836-8219-460B-BD9C-62A5C61FACEE</gtr:id><gtr:title>Serotonin receptor 1A-modulated phosphorylation of glycine receptor a3 controls breathing in mice.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af30ff65d6024f13feb378ec432b34be"><gtr:id>af30ff65d6024f13feb378ec432b34be</gtr:id><gtr:otherNames>Manzke T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>qEeA6YsP1LT</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0F8C1F7-614E-4BA7-988A-10D590E51222</gtr:id><gtr:title>Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36b912cd0a2c4a12e428a61b2969ee5f"><gtr:id>36b912cd0a2c4a12e428a61b2969ee5f</gtr:id><gtr:otherNames>Pilorge M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56d969cca80953.61622924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>289D8CEF-8CE8-45E2-8990-77D4C73251E3</gtr:id><gtr:title>The genetics of hyperekplexia: more than startle!</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47875b14997b14297da87096698f11"><gtr:id>5b47875b14997b14297da87096698f11</gtr:id><gtr:otherNames>Harvey RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>DC49E1C032E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>801FBEDC-BE28-4A19-93EE-307CCD23528E</gtr:id><gtr:title>Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor alpha3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5052234d207002d5be6b0615d5b0b99"><gtr:id>b5052234d207002d5be6b0615d5b0b99</gtr:id><gtr:otherNames>H?sl K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>2B3C80A5E1C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B13601FF-4EAE-4FF7-8078-9DDE23FA9699</gtr:id><gtr:title>Gephyrin: where do we stand, where do we go?</gtr:title><gtr:parentPublicationTitle>Trends in neurosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ddc2d6415bfae650d8989a1833ebf32"><gtr:id>5ddc2d6415bfae650d8989a1833ebf32</gtr:id><gtr:otherNames>Fritschy JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0166-2236</gtr:issn><gtr:outcomeId>70E30C77B30</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6CB38EE-EFBC-4A18-A49F-C6BBF56712BC</gtr:id><gtr:title>Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/183e6ac4be60f8d4616b329497fdfa0f"><gtr:id>183e6ac4be60f8d4616b329497fdfa0f</gtr:id><gtr:otherNames>Melzer N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>CHQ6KWG9mJj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9AD94AF6-EA3A-45A6-98FB-48B74420E137</gtr:id><gtr:title>Defective glycinergic synaptic transmission in zebrafish motility mutants.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6a7b6119ee2f9a0aee514880670869"><gtr:id>0e6a7b6119ee2f9a0aee514880670869</gtr:id><gtr:otherNames>Hirata H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>CWwmyAce2ZQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01B15859-250E-4CEB-A426-CD491B9A27A8</gtr:id><gtr:title>Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit.</gtr:title><gtr:parentPublicationTitle>The Journal of comparative neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6f9effd0d044d922b9d8b6d4a65ce65c"><gtr:id>6f9effd0d044d922b9d8b6d4a65ce65c</gtr:id><gtr:otherNames>Heinze L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9967</gtr:issn><gtr:outcomeId>141E675B5A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97AEABDF-F647-4E15-997B-9DF488388286</gtr:id><gtr:title>Control of ethanol sensitivity of the glycine receptor a3 subunit by transmembrane 2, the intracellular splice cassette and C-terminal domains.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2b98883836b90137a9aad5aeb163f6f"><gtr:id>a2b98883836b90137a9aad5aeb163f6f</gtr:id><gtr:otherNames>S?nchez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>54d3796b79dd00.49512230</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>988DAEE3-1C8C-4B39-B726-9E45239F73F9</gtr:id><gtr:title>Duplicated gephyrin genes showing distinct tissue distribution and alternative splicing patterns mediate molybdenum cofactor biosynthesis, glycine receptor clustering, and escape behavior in zebrafish.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b8df133fbf55855a53b6940cb7e482ab"><gtr:id>b8df133fbf55855a53b6940cb7e482ab</gtr:id><gtr:otherNames>Ogino K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pyzcfqUTWiQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3370922B-ACF1-4938-983F-439E430E4A19</gtr:id><gtr:title>Mapping a molecular link between allosteric inhibition and activation of the glycine receptor.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d4baceaf0e34aa81cd387370317059"><gtr:id>e5d4baceaf0e34aa81cd387370317059</gtr:id><gtr:otherNames>Miller PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>EE58A386699</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD4B224C-AC38-4549-B322-3385A8727E25</gtr:id><gtr:title>Behavioural and electrophysiological characterisation of experimentally induced osteoarthritis and neuropathy in C57Bl/6 mice.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce914547fca2be0853b0344b8e6cfa98"><gtr:id>ce914547fca2be0853b0344b8e6cfa98</gtr:id><gtr:otherNames>Harvey VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>76F74D3211A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C3827A1-B1FB-4A75-902B-A9129D7CBBFA</gtr:id><gtr:title>Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/50b0bf9255d227dc314387aa7edf0def"><gtr:id>50b0bf9255d227dc314387aa7edf0def</gtr:id><gtr:otherNames>Poulopoulos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>12C25C41423</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3757EEB5-8539-4C64-9DEA-535569315830</gtr:id><gtr:title>Mechanisms of pain in nonmalignant disease.</gtr:title><gtr:parentPublicationTitle>Current opinion in supportive and palliative care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce914547fca2be0853b0344b8e6cfa98"><gtr:id>ce914547fca2be0853b0344b8e6cfa98</gtr:id><gtr:otherNames>Harvey VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1751-4258</gtr:issn><gtr:outcomeId>39F1D7D4AEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAD1292B-DB1C-4CA8-A28D-DE5912DF3761</gtr:id><gtr:title>Glycine receptors control the generation of projection neurons in the developing cerebral cortex.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08015154e6272a0a7a5df934a5d78fd0"><gtr:id>08015154e6272a0a7a5df934a5d78fd0</gtr:id><gtr:otherNames>Avila A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>545c99bd636ad0.32750674</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE1AA836-E40D-48C9-AAD0-EFBBBD8AAE76</gtr:id><gtr:title>Glycinergic transmission in the Mammalian retina.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c8d3a868370a731c1829c28bf3c1052"><gtr:id>0c8d3a868370a731c1829c28bf3c1052</gtr:id><gtr:otherNames>W?ssle H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>8BFA39DCFB1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24475116-28CB-44EA-B9AD-AC246AAE02B7</gtr:id><gtr:title>Cerebral Cortical Circuitry Formation Requires Functional Glycine Receptors.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/548d69ae1aace35491906dceca45ac27"><gtr:id>548d69ae1aace35491906dceca45ac27</gtr:id><gtr:otherNames>Morelli G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>56d96903dcca78.45419849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBD7434C-7BCA-49F0-8243-A2A47FA85DA7</gtr:id><gtr:title>Spinal cord mechanisms of pain.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85de5bc61bef36fdc86b246f477d2b94"><gtr:id>85de5bc61bef36fdc86b246f477d2b94</gtr:id><gtr:otherNames>D'Mello R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn><gtr:outcomeId>5B0C020B8D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7F395CE-F3D3-43A6-8EEC-CDED3BC07FA9</gtr:id><gtr:title>Binding, activation and modulation of Cys-loop receptors.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d4baceaf0e34aa81cd387370317059"><gtr:id>e5d4baceaf0e34aa81cd387370317059</gtr:id><gtr:otherNames>Miller PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>bRoDQ7sUYNn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>862E8D15-75C6-4071-B81D-31F09EFE408A</gtr:id><gtr:title>Distinct phenotypes in zebrafish models of human startle disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/174a7e4cdffd550efe0ce046c1e8b00e"><gtr:id>174a7e4cdffd550efe0ce046c1e8b00e</gtr:id><gtr:otherNames>Ganser LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_12997_27_24029548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5B1AD70-2DE1-4412-A5EF-94C37572871F</gtr:id><gtr:title>Glycine and glycine receptor signalling in non-neuronal cells.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bb778ce8386308547c149d712ebfe8"><gtr:id>d8bb778ce8386308547c149d712ebfe8</gtr:id><gtr:otherNames>Van den Eynden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>BF656BE63ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6267DB58-2106-4BAE-AAD5-F94E69DDAF36</gtr:id><gtr:title>A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf9c2d3260e115f51a5ebf8d4d07d149"><gtr:id>bf9c2d3260e115f51a5ebf8d4d07d149</gtr:id><gtr:otherNames>Yang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>F2B9ECF3AE9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51B984E5-028D-4896-87E1-B1ED4DAAB62F</gtr:id><gtr:title>Murine startle mutant Nmf11 affects the structural stability of the glycine receptor and increases deactivation.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed0fd074168237c1eedafa78e4dc1a0c"><gtr:id>ed0fd074168237c1eedafa78e4dc1a0c</gtr:id><gtr:otherNames>Wilkins ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>58a3c79dd2a3b2.80186913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59F0F78D-0BC5-4379-91C5-D2C909739FDD</gtr:id><gtr:title>Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf9c2d3260e115f51a5ebf8d4d07d149"><gtr:id>bf9c2d3260e115f51a5ebf8d4d07d149</gtr:id><gtr:otherNames>Yang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>1201942CB41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A3439A4-1A25-4FB9-92FD-B2885BF8D6E3</gtr:id><gtr:title>A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf78972f5de4dacb7cdfb7477da0301f"><gtr:id>bf78972f5de4dacb7cdfb7477da0301f</gtr:id><gtr:otherNames>Kalscheuer VM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>423337ABC2D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>328E9630-38E2-4F8D-AB27-401A5F58D568</gtr:id><gtr:title>Tonically Active a2 Subunit-Containing Glycine Receptors Regulate the Excitability of Striatal Medium Spiny Neurons.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4b8ca48157123bb7f1a59ccda5a7dfd"><gtr:id>a4b8ca48157123bb7f1a59ccda5a7dfd</gtr:id><gtr:otherNames>Molchanova SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>5a6791d4557209.08571508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8720F4E5-1AFB-4D48-A139-5FFB6DDBEECD</gtr:id><gtr:title>Glycine receptor a2 subunit activation promotes cortical interneuron migration.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08015154e6272a0a7a5df934a5d78fd0"><gtr:id>08015154e6272a0a7a5df934a5d78fd0</gtr:id><gtr:otherNames>Avila A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_12997_27_23954789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD7A05F9-0399-4379-8081-DC71323FE05E</gtr:id><gtr:title>Dihydropyridine inhibition of the glycine receptor: subunit selectivity and a molecular determinant of inhibition.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7771ec39b9bd63d704f50fabca5f24ae"><gtr:id>7771ec39b9bd63d704f50fabca5f24ae</gtr:id><gtr:otherNames>Chen X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>EFA72A26E4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB7F0B5-D609-415D-A488-8F7835BC36D9</gtr:id><gtr:title>[Serotonin receptor 1A-modulated dephosphorylation of glycine receptor a3: a new molecular mechanism of breathing control for compensation of opioid-induced respiratory depression without loss of analgesia].</gtr:title><gtr:parentPublicationTitle>Schmerz (Berlin, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af30ff65d6024f13feb378ec432b34be"><gtr:id>af30ff65d6024f13feb378ec432b34be</gtr:id><gtr:otherNames>Manzke T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0932-433X</gtr:issn><gtr:outcomeId>DwUxNHstTZB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9FC9EDD-B145-450A-8F50-BABBE1DBDDB3</gtr:id><gtr:title>A Selective Role for alpha3 Subunit Glycine Receptors in Inflammatory Pain.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce914547fca2be0853b0344b8e6cfa98"><gtr:id>ce914547fca2be0853b0344b8e6cfa98</gtr:id><gtr:otherNames>Harvey VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>DF8DA70DCE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A969A9D-B26B-483C-AEF7-DAB08BABF45D</gtr:id><gtr:title>Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47875b14997b14297da87096698f11"><gtr:id>5b47875b14997b14297da87096698f11</gtr:id><gtr:otherNames>Harvey RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>pm_12997_27_24172334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E986CC5C-4110-4736-AEB3-4E17A8827C4B</gtr:id><gtr:title>Defective escape behavior in DEAH-box RNA helicase mutants improved by restoring glycine receptor expression.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e6a7b6119ee2f9a0aee514880670869"><gtr:id>0e6a7b6119ee2f9a0aee514880670869</gtr:id><gtr:otherNames>Hirata H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_12997_27_24027265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26B9F85A-7D99-4A7B-8350-071FD2E6DDED</gtr:id><gtr:title>Plasticity of synaptic inhibition in mouse spinal cord lamina II neurons during early postnatal development and after inactivation of the glycine receptor alpha3 subunit gene.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ff5a25d4c258ecc94c48af2007562c8"><gtr:id>8ff5a25d4c258ecc94c48af2007562c8</gtr:id><gtr:otherNames>Rajalu M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>gbDNFNwRExX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D821EAB4-BF55-408A-BF8E-5318347EA7C5</gtr:id><gtr:title>Glycinergic transmission: physiological, developmental and pathological implications.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b47875b14997b14297da87096698f11"><gtr:id>5b47875b14997b14297da87096698f11</gtr:id><gtr:otherNames>Harvey RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>CXNQ8LWJeci</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500833</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>